{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:59:52Z","timestamp":1791248392307,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The interleukin-36 receptor antagonist (IL-36Ra) which regulates IL-36\u03b1, -\u03b2 and -\u03b3 is linked to psoriatic inflammation, especially loss-of-function mutations in pustular psoriasis subtypes. As observed with other IL-1 superfamily proteins, the IL-36 members require N-terminal cleavage for full biological activity but the mechanisms of IL-36Ra activation remain poorly defined. Using different blood leukocyte and skin resident cell preparations and recombinant proteins, we have identified that neutrophil elastase, but not other neutrophil derived proteases, cleaves IL-36Ra into its highly active antagonistic form. The activity of this processed form of IL-36Ra was confirmed in human primary dermal fibroblasts and keratinocytes and in skin equivalents. A significant dose dependent reduction of IL-36\u03b3 induced IL-8 and chemokine ligand 20 (CCL20) levels were detected following addition of the cleaved IL-36Ra compared to full length IL-36Ra. By activating IL-36Ra, the neutrophil derived protease can inhibit IL-36 induced chemokine production, including IL-8 and CCL20 and reduce further inflammatory cell infiltration. These findings strongly indicate neutrophil elastase to be a key enzyme in the biological function of IL-36Ra and that neutrophils can play a regulatory role in psoriatic inflammation with regard to balancing the pro-inflammatory activity of IL-36.<\/jats:p>","DOI":"10.1038\/srep24880","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T09:24:59Z","timestamp":1461317099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist"],"prefix":"10.1038","volume":"6","author":[{"given":"Tom","family":"Macleod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Doble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Wasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewonuola","family":"Alase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"BFsrep24880_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N Engl J Med. 361, 496\u2013509 (2009).","journal-title":"N Engl J Med."},{"key":"BFsrep24880_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/BOR.0b013e3283031c99","volume":"20","author":"RS Azfar","year":"2008","unstructured":"Azfar, R. S. & Gelfand, J. M. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol. 20, 416\u2013422 (2008).","journal-title":"Curr Opin Rheumatol."},{"key":"BFsrep24880_CR3","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1084\/jem.20060244","volume":"203","author":"JR Chan","year":"2006","unstructured":"Chan, J. R. et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med. 203, 2577\u20132587 (2006).","journal-title":"J Exp Med."},{"key":"BFsrep24880_CR4","first-page":"597","volume":"118","author":"HL Ma","year":"2008","unstructured":"Ma, H. L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 118, 597\u2013607 (2008).","journal-title":"J Clin Invest."},{"key":"BFsrep24880_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/jid.2014.532","volume":"135","author":"AM D\u2019Erme","year":"2015","unstructured":"D\u2019Erme, A. M. et al. IL-36gamma (IL-1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol. 135, 1025\u20131032 (2015).","journal-title":"J Invest Dermatol."},{"key":"BFsrep24880_CR6","doi-asserted-by":"publisher","first-page":"13677","DOI":"10.1074\/jbc.M400117200","volume":"279","author":"JE Towne","year":"2004","unstructured":"Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D. & Sims, J. E. Interleukin (IL)-1F6, IL-1F8 and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem. 279, 13677\u201313688 (2004).","journal-title":"J Biol Chem."},{"key":"BFsrep24880_CR7","doi-asserted-by":"publisher","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","volume":"286","author":"JE Towne","year":"2011","unstructured":"Towne, J. E. et al. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta and IL-36gamma) or antagonist (IL-36Ra) activity. J Biol Chem. 286, 42594\u201342602 (2011).","journal-title":"J Biol Chem."},{"key":"BFsrep24880_CR8","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1084\/jem.20070157","volume":"204","author":"H Blumberg","year":"2007","unstructured":"Blumberg, H. et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med. 204, 2603\u20132614 (2007).","journal-title":"J Exp Med."},{"key":"BFsrep24880_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 365, 620\u2013628 (2011).","journal-title":"N Engl J Med."},{"key":"BFsrep24880_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.4049\/jimmunol.1400538","volume":"193","author":"S Gunther","year":"2014","unstructured":"Gunther, S. & Sundberg, E. J. Molecular Determinants of Agonist and Antagonist Signaling through the IL-36 Receptor. J Immunol. 193, 921\u2013930 (2014).","journal-title":"J Immunol."},{"key":"BFsrep24880_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/humu.22203","volume":"34","author":"M Farooq","year":"2013","unstructured":"Farooq, M. et al. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum Mutat. 34, 176\u2013183 (2013).","journal-title":"Hum Mutat."},{"key":"BFsrep24880_CR12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","volume":"14","author":"CM Henry","year":"2016","unstructured":"Henry, C. M. et al. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines. Cell Rep. 14, 708\u2013722 (2016).","journal-title":"Cell Rep"},{"key":"BFsrep24880_CR13","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","volume":"118","author":"S Vigne","year":"2011","unstructured":"Vigne, S. et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood. 118, 5813\u20135823 (2011).","journal-title":"Blood."},{"key":"BFsrep24880_CR14","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","volume":"192","author":"AM Foster","year":"2014","unstructured":"Foster, A. M. et al. IL-36 Promotes Myeloid Cell Infiltration, Activation and Inflammatory Activity in Skin. J Immunol. 192, 6053\u20136061 (2014).","journal-title":"J Immunol."},{"key":"BFsrep24880_CR15","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/jid.2011.234","volume":"131","author":"Y Carrier","year":"2011","unstructured":"Carrier, Y. et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol. 131, 2428\u20132437 (2011).","journal-title":"J Invest Dermatol."},{"key":"BFsrep24880_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/eji.201142035","volume":"42","author":"S Mutamba","year":"2012","unstructured":"Mutamba, S., Allison, A., Mahida, Y., Barrow, P. & Foster, N. Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9. Eur J Immunol. 42, 607\u2013617 (2012).","journal-title":"Eur J Immunol."},{"key":"BFsrep24880_CR17","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","volume":"20","author":"M Friedrich","year":"2014","unstructured":"Friedrich, M., Tillack, C., Wollenberg, A., Schauber, J. & Brand, S. IL-36gamma sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn\u2019s disease. Inflamm Bowel Dis. 20, 1891\u20131901 (2014).","journal-title":"Inflamm Bowel Dis."},{"key":"BFsrep24880_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/jir.2008.0139","volume":"28","author":"R Parsanejad","year":"2008","unstructured":"Parsanejad, R., Fields, W. R., Steichen, T. J., Bombick, B. R. & Doolittle, D. J. Distinct regulatory profiles of interleukins and chemokines in response to cigarette smoke condensate in normal human bronchial epithelial (NHBE) cells. J Interferon Cytokine Res. 28, 703\u2013712 (2008).","journal-title":"J Interferon Cytokine Res."},{"key":"BFsrep24880_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/mi.2009.109","volume":"3","author":"YA Bochkov","year":"2010","unstructured":"Bochkov, Y. A. et al. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 3, 69\u201380 (2010).","journal-title":"Mucosal Immunol"},{"key":"BFsrep24880_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1152\/physiolgenomics.00289.2004","volume":"21","author":"JB Vos","year":"2005","unstructured":"Vos, J. B. et al. Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense. Physiol Genomics. 21, 324\u2013336 (2005).","journal-title":"Physiol Genomics."},{"key":"BFsrep24880_CR21","doi-asserted-by":"publisher","first-page":"e45784","DOI":"10.1371\/journal.pone.0045784","volume":"7","author":"RA Ramadas","year":"2012","unstructured":"Ramadas, R. A., Ewart, S. L., Iwakura, Y., Medoff, B. D. & LeVine, A. M. IL-36alpha exerts pro-inflammatory effects in the lungs of mice. Plos One. 7, e45784 (2012).","journal-title":"Plos One."},{"key":"BFsrep24880_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/eji.201242711","volume":"43","author":"MS Gresnigt","year":"2013","unstructured":"Gresnigt, M. S. et al. The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses. Eur J Immunol. 43, 416\u2013426 (2013).","journal-title":"Eur J Immunol."},{"key":"BFsrep24880_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molcel.2011.07.037","volume":"44","author":"IS Afonina","year":"2011","unstructured":"Afonina, I. S. et al. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alpha. Mol Cell. 44, 265\u2013278 (2011).","journal-title":"Mol Cell."},{"key":"BFsrep24880_CR24","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1016\/S0021-9258(19)76559-4","volume":"263","author":"RA Black","year":"1988","unstructured":"Black, R. A. et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem. 263, 9437\u20139442 (1988).","journal-title":"J Biol Chem."},{"key":"BFsrep24880_CR25","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1016\/S0021-9258(19)39328-7","volume":"265","author":"DJ Hazuda","year":"1990","unstructured":"Hazuda, D. J., Strickler, J., Kueppers, F., Simon, P. L. & Young, P. R. Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem. 265, 6318\u20136322 (1990).","journal-title":"J Biol Chem."},{"key":"BFsrep24880_CR26","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1002\/art.25006","volume":"60","author":"LA Joosten","year":"2009","unstructured":"Joosten, L. A. et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 60, 3651\u20133662 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFsrep24880_CR27","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.1115884109","volume":"109","author":"E Lefrancais","year":"2012","unstructured":"Lefrancais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109, 1673\u20131678 (2012).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep24880","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep24880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:12:57Z","timestamp":1672841577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep24880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,6]]}},"alternative-id":["BFsrep24880"],"URL":"https:\/\/doi.org\/10.1038\/srep24880","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]},"assertion":[{"value":"7 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24880"}}